Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 December 2022 | Story Lacea Loader | Photo Supplied
Prof Serges Kamga
Prof Serges Kamga, newly appointed Dean: Faculty of Law.

The Council of the University of the Free State (UFS) approved the appointment of Prof Serges Kamga as Dean of the Faculty of Law for a five-year term during its quarterly meeting on 25 November 2022. 

Prof Kamga is a full Professor of Law currently working at the Thabo Mbeki African School of Public and International Affairs (TMS) at the University of South Africa (UNISA).

“Prof Kamga’s excellent research reputation nationally and internationally, his extensive networks and partnerships will contribute to further raising the profile of the Faculty of Law nationally, on the continent and globally.  As an established NRF-rated researcher, he will also be able to enhance the research output of the faculty,” says Prof Francis Petersen, UFS Rector and Vice-Chancellor. 

“Prof Kamga will lead and manage the Faculty of Law in support of the UFS’ Vision 130 and the ultimate intent for the coming years to be a research-led, student-centred, and regionally engaged university that contributes to development and social justice through the production of globally competitive graduates and knowledge, and that impactfully supports societal development,” says Prof Petersen.  

Prof Kamga is co-director of the Cross-Cultural Human Rights Centre at the Free University of Amsterdam in the Netherlands. At times, he has acted as head of the Thabo Mbeki African Leadership Institute currently Thabo Mbeki School at UNISA and has had engagements at the United States Agency for International Development (USAID), the Young African Leaders Initiative, and as managing consultant at African Legal Sources at the University of Pretoria. In 2021, he received the prestigious Ali Mazrui Award for Scholarship and Research Excellence from the University of Texas at Austin in the USA.

He holds an LLD degree in Human Rights Law from the Centre for Human Rights, University of Pretoria. Prof Kamga has also worked as a researcher at the South African Institute for Advanced Constitutional, Public, Human Rights and International Law (SAIFAC). As a researcher, he has published in accredited journals and presented papers at various national and international conferences. 

“Prof Kamga’s experience in these positions, as well as his extensive knowledge and understanding of the South African and global law fraternity, places him in good standing to lead the faculty to become a formidable and impactful force nationally, on the continent, and abroad. He will also lead the faculty to exploit opportunities and deal with the challenges that the rapidly changing higher-education environment has to deal with,” says Prof Petersen.

Prof Kamga will assume duty on 1 February 2023.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept